Intelligence Platform

Patents

Browse 140 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10434117

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Julius-Maximilians-Universitat Wurzburg · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10435373

Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggrega

Ludwig-Maximilians-Universitat Munchen · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10408834

Mutated parvovirus structural proteins as vaccines

Ludwig-Maximilians-Universitat Munchen · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10293037

DNA vaccine for use in pancreatic cancer patients

Vaximm AG · Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10272051

Method to treat atopic dermatitis

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10261095

Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment

Julius-Maximilians-Universitat Wurzburg · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10253294

Galactose oxidase treatment of dendritic cells to improve their immunogenicity

Julius-Maximilians-Universitat Wurzburg · Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10172786

Oral care composition comprising cannabinoids

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10105414

Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal

Julius-Maximilians-Universitat Wurzburg · Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10092538

Suppositories comprising cannabinoids

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10071966

Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggrega

Ludwig-Maximilians-Universitat Munchen · Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10028974

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Julius-Maximilians-Universitat Wurzburg · Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10010571

Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat,

Maximum Human Performance, LLC · Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9957329

Factor XII inhibitors for the treatment of neurological inflammatory disorders

Julius-Maximilians-Universitat Wurzburg · Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9920297

Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1

Vaximm AG · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9844530

Ophthalmic solutions for glaucoma and conjunctivitis treatment

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9839684

Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic

BIOVAXIM LIMITED · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9814789

Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

Julius-Maximilians-Universitat Wurzburg · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9814695

Ophthalmic solutions for glaucoma and conjunctivitis treatment

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801938

Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists

FREISTAAT BAYERN REPRESENTED BY JULIUS-MAXIMILLIANS-UNIVERSITÄT WÜRZBURG · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9750717

Inhibitors of CD40-TRAF6 interaction

Ludwig-Maximilians-Universitat Munchen · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9718811

(S)-enantiomer of mepazine

Ludwig-Maximilians-Universitat Munchen · Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9678061

Identification of T cell target antigens

Ludwig-Maximilians-Universitat Munchen · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663788

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Julius-Maximilians-Universitat Wurzburg · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted